血清胱抑素C在呼吸系统疾病中的应用研究进展  

Research progress on the application of serum cystatin C in respiratory diseases

作　　者：金文珍 穆清爽[2] JIN Wenzhen;MU Qingshuang(the Second Affiliated Hospital of Xinjiang Medical University,Urumqi,Xinjiang 830063,China;Department of Geriatrics,the Second Affiliated Hospital of Xinjiang Medical University,Urumqi,Xinjiang 830063,China)

机构地区：[1]新疆医科大学第二附属医院,新疆乌鲁木齐830063 [2]新疆医科大学第二附属医院老年病科,新疆乌鲁木齐830063

出　　处：《现代医药卫生》2025年第2期464-467,473,共5页Journal of Modern Medicine & Health

基　　金：新疆维吾尔自治区自然科学基金(2021D01C371)。

摘　　要：血清胱抑素C(Cys C)作为重要的生物标志物,在急性心肌梗死、心力衰竭、动脉粥样硬化、急性脑梗死、帕金森等心脑血管疾病的早期诊断和远期预后具有重要的临床价值。该文通过分析总结血清Cys C的特性并基于慢性阻塞性肺疾病、肺部恶性肿瘤、新型冠状病毒肺炎等呼吸系统常见疾病,对血清Cys C在呼吸系统疾病中的应用研究进行综述。As an important biomarker,serum cystatin C(Cys C)has important clinical value in the early diagnosis and long-term prognosis of cardiovascular and cerebrovascular diseases,such as acute myocardial infarction,heart failure,atherosclerosis,acute cerebral infarction,and Parkinson’s disease.This article analyzed and summarized the characteristics of serum Cys C and reviewed the application of serum Cys C in respiratory diseases based on common respiratory diseases such as chronic obstructive pulmonary disease,lung malignant tumors and novel coronavirus pneumonia.

关 键 词：血清胱抑素C 呼吸系统疾病 综述 

分 类 号：R563[医药卫生—呼吸系统]